EPHB1 and cancer: The treatment of EphrinB2-Fc on A549 cells increased the ratio of CD133+ cancer stem cells and knockdown of Sox2 and Nanog by siRNA could reverse the enrichment of cancer stem cells induced by EphB1 trans signaling (Fig. 8C, D).